Skip to main content
Fig. 2 | BMC Medicine

Fig. 2

From: Genetic variation in clusterin and risk of dementia and ischemic vascular disease in the general population: cohort studies and meta-analyses of 362,338 individuals

Fig. 2

Risk of dementia and ischemic vascular disease as a function of rs9331896. Hazard ratios were multifactorially adjusted for age, sex, body mass index, hypertension, diabetes mellitus, smoking, alcohol consumption, physical inactivity, menopausal status and hormonal replacement therapy (only women), lipid-lowering therapy, and education (left panel). Hazard ratios were further adjusted for APOE genotype (middle panel). Analyses for Alzheimer’s disease, all dementia, and vascular dementia included 103,987 individuals. Analyses for ischemic cerebrovascular disease included 100,894 individuals and analysis for ischemic heart disease included 96,223 individuals. Analysis of individuals with the APOE ε33 genotype only included 57,923 individuals for Alzheimer’s disease, all dementia, and vascular dementia, 56,184 for ischemic cerebrovascular disease, and 53,538 for ischemic heart disease (right panel)

Back to article page